CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Amneal Pharmaceuticals, Inc.

AMRX
$6.09BMid Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for AMRX. That does not mean none is planned.

Get an email about AMRX's next catalysts

Track Amneal Pharmaceuticals (AMRX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth America8.1K employees

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.

Website

Frequently asked questions

What is in Amneal Pharmaceuticals, Inc.'s drug pipeline?β†’

CatalystAlert tracks 9 drug candidates in Amneal Pharmaceuticals, Inc.'s (AMRX) pipeline across Phase 3. Its lead program is Asenapine Sublingual (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Amneal Pharmaceuticals, Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Amneal Pharmaceuticals, Inc. (AMRX) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track AMRX biotech catalysts?β†’

Add AMRX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Amneal Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply